Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 242 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 2 | 4 | 10 | 10 | 6 | 11 | 3 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 217 |
| Views | |
|---|---|
| United States | 51 |
| Argentina | 38 |
| Canada | 27 |
| Peru | 20 |
| Mexico | 10 |
| Paraguay | 9 |
| Spain | 7 |
| Bolivia | 5 |
| Germany | 4 |
| Ecuador | 4 |
| Views | |
|---|---|
| Ottawa | 26 |
| Buenos Aires | 9 |
| Lima | 9 |
| Menlo Park | 7 |
| San Diego | 7 |
| La Paz | 5 |
| Mexico | 5 |
| Falls Church | 4 |
| Federal | 4 |
| San Lorenzo | 4 |